ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Juno Explodes on Celgene Takeover Rumors
biospace
January 18, 2018Rumors?that?Celgene Corporation?is in talks to acquire?Juno Therapeutics?has caused Juno’s stock to rocket more than 50 percent to $68.80 in premarket trading. -
Juno ends development of CAR-T therapy JCAR015 following patient deaths
firstwordpharma
March 03, 2017Juno Therapeutics said that it will end development of the experimental CAR-T therapy JCAR015 in adults with relapsed or refractory acute lymphoblastic leukaemia (ALL) following safety issues observed in a mid-stage trial.
Pharma Sources Insight January 2025
